Spinner Technologies

Spinner Technologies is an Australian biotechnology company that specializes in the development of advanced 3D cell culture platforms. The company's flagship technology, the Spinner platform, is designed to enable the high-throughput production of uniform 3D cell models, such as spheroids and organoids, which are critical for drug discovery and regenerative medicine. By providing a more physiologically relevant environment than traditional 2D cultures, Spinner's technology helps researchers better predict human responses to new therapeutics. In 2021, the company was acquired by Sartorius, a leading international partner of life science research and the biopharmaceutical industry, to enhance their portfolio in cell culture and cell therapy applications.